Free radicals are highly reactive molecules generated predominantly during cellular respiration and normal metabolism. Imbalance between the cellular production of free radicals and the ability of cells to defend against them is referred to as oxidative stress (OS). Biological systems use enzymatic (superoxide dismutase, glutathione peroxidase, etc.) and nonenzymatic (uric acid, creatinine, polyamine, retinal, etc.) antioxidant systems to prevent OS. However, once the systems are disturbed the uncontrolled oxidative stresses initiate a series of harmful biochemical events or generate them as a consequence of earlier tissue injury, thus aggravating the final damages. Such damages include brain dysfunction, cancer, and cardiovascular disease and inflammation. 1,2) Selenium is an essential trace element and has been known to be intimately involved in the activity of enzymes such as glutathione peroxidase (GSH Px) and thioredoxin reductase, which catalyze chemistry essential to the protection of biomolecules against OS and free radical damage.3) Although possessing potent antioxidative activity, like other protein drugs GSH Px is limited for clinical use due to the instability and immunogenicity of the endogenous forms. To circumvent the intrinsic difficulties of using natural enzymes as drugs, several attempts have been made to produce synthetic compounds that mimic the properties of GSH Px. Ebselen, 4) 2-phenylbenzisoselenazole-3(2H)-one, was the most successful compound and showed anti-inflammatory, anti-atherosclerotic, and cytoprotective activities. These biological activities are attributed partly to the strong tendency of selenium to undergo redox reactions. Therefore, in the design of novel antioxidants as therapeutic agents there are a number of approaches utilizing the redox properties of selenium and incorporating selenium into the molecule skeleton. Review articles have summarized the synthesis and properties of a considerable number of organoselenium compounds prepared as potential pharmaceuticals.
5-7)Caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester (CAPE, 1; Fig. 1), a kind of polyphenolic acid, is an active component of propolis from honeybee hives. It has antiviral, anti-inflammatory, and immunomodulatory properties 8) and has been shown to inhibit the growth of different types of transformed cells. [8][9][10][11][12][13] In transformed cells, CAPE alters the redox state and induces apoptosis.14) It has been reported that CAPE suppresses lipid peroxidation, 15) displays antioxidant activity, 16) and inhibits ornithine decarboxylase, protein tyrosine kinase (PTK), and lipoxygenase activities. [17][18][19][20] CAPE can also inhibit phorbol ester-induced H 2 O 2 production and tumor promotion. 21,22) In recent years, studies in our laboratory have been directed at synthetic antioxidants with diverse anti-oxidative functionalities. [23][24][25] Based on the unique anti-oxidative properties of selenium, we speculated that ester analogues of polyphenolic acid and phenylselenoethanol, such as 2 ...